Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

Pfizer (PFE) shares have shown some movement this week, drawing attention for investors evaluating the company’s current ...

Fintel reports that on December 2, 2025, Citigroup reiterated coverage of Pfizer (NYSE:PFE) with a Neutral recommendation.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.

Worries about regulatory headwinds weighed on vaccine producers on Monday, Dec. 1, 2025, while a chip design software maker got a boost from a partnership with an AI darling.

Altria Group Inc. ( NYSE: MO) is one of the world’s largest producers and marketers of cigarettes and other smokable and oral ...

According to TipRanks.com, Sulewski is a 4-star analyst with an average return of 8.0% and a 48.5% success rate. Sulewski covers the Healthcare sector, focusing on stocks such as Collegium ...

The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...